Health follow-up for children born after assisted reproductive techniques
Official title: Enhancing Algorithms for the Management of Children Conceived by Assisted Reproductive Technologies Based on a Comprehensive Assessment of the Impact of Modern Methods of Conception on Their Health Status
Run by Kazakhstan's Medical University "KSPH" · NCT07278960 · Data updated 2026-11-12
This project will see if children up to 36 months conceived by IVF, ICSI, or frozen embryo transfer have differences in growth, neurological development, or reproductive markers compared with expected norms.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Months to 3 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Kazakhstan's Medical University "KSPH" Academic / other |
| Locations | 1 site (Almaty) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | November 30, 2027 |
| Registry record updated | December 12, 2025 |
| Trial ID | NCT07278960 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children from birth up to 36 months conceived by IVF, ICSI, or fresh/frozen embryo transfer with complete perinatal and ART documentation and parental consent, plus consenting mothers (and fathers for ICSI subgroup) willing to provide medical history.
✕Probably not a fit
Children older than 36 months, those not conceived via ART, or those without complete perinatal/ART records are unlikely to benefit from this study's findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will analyze clinical and anamnestic data from about 300 children born after advanced ART methods in Kazakhstan. Investigators will combine a retrospective review of perinatal and parental medication history with in-person assessments of anthropometrics, somatic health, basic neurological screening, and targeted urogenital examinations. Male children in the ICSI subgroup will have reproductive hormones (inhibin B, AMH) measured to characterize endocrine profiles. Results will be used to inform management principles and referral pathways tailored to children conceived by ART.
Why it matters
Potential benefit: If successful, the study could help clinicians detect early health differences and create tailored follow-up and referral plans for children conceived by ART.
How similar studies have gone: Previous observational studies have reported modest perinatal and growth differences in ART-conceived offspring, but findings on neurological and reproductive outcomes are mixed and remain inconclusive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: For children: * Born as a result of an ART program (IVF, ICSI, FET, or Fresh-ET). * Age at the time of assessment: from birth up to 36 months. * Availability of complete perinatal and medical documentation, including ART cycle characteristics and neonatal outcomes. * Informed consent provided by parents or legal guardians for participation in the study and for biological sample collection (where applicable). For mothers: * History of pregnancy achieved through ART within the territory of Kazakhstan. * Availability of data on pharmacological treatment before and during pregnancy (e.g., hormonal therapy, antithyroid drugs, vitamins, micronutrients). * Willingness to provide anamnestic and perinatal information, and consent for access to medical records. For fathers (in ICSI subgroup): * Documented infertility factor necessitating ICSI. * Agreement to provide relevant medical history and participate in comparative analyses (e.g., endocrine or reproductive parameters of father-son pairs).
Where it's running
-
Международный клинический центр репродуктологии Persona
Almaty, Kazakhstan Recruiting
Study contacts
- Study coordinator: Sevara Ilmuratova, PhD
- Email: ilmuratova.s@gmail.com
- Phone: +77778017305
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Standardizing embryo transfer steps for frozen embryo transfers
This trial tests whether using specialized transfer devices to keep embryos warm and deliver them with precise, controlled motion can increase pregnancy success for people having frozen embryo transfer after IVF/ICSI.
-
Pre-eclampsia risk in pregnancies after oocyte donation
We will follow pregnant women who used donated eggs and women who used their own eggs to see if pregnancies after oocyte donation lead to a higher risk of pre-eclampsia.
-
Combining immune-enhancing antibodies and vaccines to control HIV after early infection
This test will see if giving long-acting HIV antibodies together with therapeutic vaccines helps people who began ART during acute HIV infection control viral levels after a planned treatment interruption.
-
Investigating cardiometabolic health in mothers and children after assisted reproductive technology
This study is trying to understand the health of mothers and their children conceived through different methods, like frozen or fresh embryo transfers, to see how these methods affect their heart and metabolic health during and after pregnancy.
-
Using aspirin to prevent preeclampsia in women after assisted reproductive technology
This study is testing if taking aspirin during early pregnancy can help prevent preeclampsia in women who are at high risk and became pregnant through assisted reproductive technology.
-
Using AI to improve IVF and ART outcomes
This study is testing whether using artificial intelligence can help doctors better predict the success of IVF treatments by analyzing patient data and ultrasound images.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.